Notable Drug Approvals.

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.

The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.

US health officials have informed more than half a dozen leading medical organizations that they will no longer be invited to participate in developing vaccination recommendations.

Spencer C. Payne, M.D., from the University of Virginia in Charlottesville, and colleagues updated the guidelines published in 2015 to address quality improvement opportunities for managing adult ...

The FDA has granted accelerated approval to Hernexeos for the treatment of adults with unresectable or metastatic non-squamous NSCLC.

In patients with asthma, long-term FEV1 reduction may be independently predicted by high BMI, which is a modifiable risk factor.

Treatment of multisystem inflammatory syndrome in children, a postacute sequela of SARS-CoV-2, with larazotide speeds resolution of GI symptoms and clearance of spike antigen.

Vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage was not associated with an increased risk for 29 adverse events.

RSV hospitalization was associated with increased risk for new CVEs and worsening of preexisting cardiovascular conditions.

Baseline obesity is associated with poorer sleep quality, reduced sleep efficiency, and greater sleep latency in children with OSA syndrome.

COVID-19 vaccination during 2020 to 2024 was beneficial, but estimates are more conservative than previous calculations that focused on the first year of vaccinations.